Press Releases Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Delayed Deutsche Boerse AG Other stock markets 11:30:18 03/07/2024 am IST			5-day change	1st Jan Change
0.81 ^EUR	+7.28%		+1.89%	-25.00%

28/05	Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	MT
28/05	Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice	28/05	AQ
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates	20/05	AQ
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel	16/05	AQ
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	01/04	AQ
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	13/03	AQ
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	30/11	AQ
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	28/11	AQ
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	20/11	PU
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	09/11	AQ
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30/23/30	AQ
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10/23/10	AQ
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21/23/21	PU
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14/23/14	PU
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06/23/06	AQ
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update	12/23/12	AQ
Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference	20/23/20	AQ
Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments	10/23/10	AQ
Sol Gel Technologies : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K	01/23/01	PU
Sol Gel Technologies : Gel Corporate Presentation	02/23/02	PU
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings	30/23/30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Press Releases

Filters